TISMOO is the first company in the world exclusively dedicated to genetic analysis, focused in personalized therapeutic perspectives for the Autism Spectrum Disorder and other genetic neurological disorders such as Rett Syndrome, Timothy Syndrome, Fragile X Syndrome, Angelman Syndrome and Phelan-McDermid Syndrome.

Personalized Medicine for an effective treatment.

The technologies associated to the human Geenome and Stem Cells are revolutionizing the healthcare systems across the world. TISMOO intends to contribute to that future through personalized medicine.